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Introduction
Noninvasive brain stimulation protocols have been widely used to examine neuronal plasticity in humans (Classen 2013) or as a possible therapeutic tool in neuropsychiatric patients (Lefaucheur et al. 2014) . Paired associative stimulation (PAS), employing repetitive pairings of TMS over the human motor cortex with an afferent pulse providing input to the congruent motor region (Stefan et al. 2000) , shares design principles with experimental protocols inducing synaptic spike timingdependent plasticity (STDP) in vitro (Dan and Poo 2004) . PAS-induced plasticity is frequently regarded as an in-vivo model of STDP of excitatory glutamatergic synapses (Müller-Dahlhaus et al. 2010) , although other physiological mechanisms like increased cortical network activity (Thickbroom 2007) , changes of local inhibitory interneuronal circuits or intrinsic excitability (Carson and Kennedy 2013 ) may contribute to its effects. Similarly, the effects induced by theta-burst stimulation (TBS)-a repetitive magnetic stimulation protocol (Huang et al. 2005) consisting of 50-Hz triplets of subthreshold magnetic stimuli repeated at 5 Hz-have been likened to long-term potentiation (LTP)/long-term depression (LTD) of synaptic plasticity because of its similarity with a standard protocol (Larson and Munkácsy 2015) , used to induce synaptic plasticity in vitro, and because it shares physiological properties with TBS-induced effects on glutamatergic synapses (Huang et al. 2005; Cárdenas-Morales et al. 2010) . PAS and TBS differ in the role of sensory input, which is prominent in PAS, but absent in TBS. Furthermore, the archetypical STDP paradigm, which PAS is based upon, requires the postsynaptic neuron to fire action potentials backpropagating into the neuron's dendritic tree in addition to a presynaptic input (Markram et al. 1997 ). Conversely, in animal studies TBS-induced plasticity may rely on cooperative dendritic activity of presynaptic input alone and does not require somatic action potential firing of the postsynaptic neuron (Golding et al. 2002) . These facts implicate that plastic changes evoked by either protocol are regulated by different mechanisms, despite the similarity of their effects on some physiological outcome measures.
Pharmacological in vitro (Higley and Sabatini 2012) and modelling (Graupner and Brunel 2012) studies suggest that most forms of synaptic plasticity are controlled by activitydependent surges of intracellular [Ca 2+ ] resulting from Ca 2+ -influx through N-methyl-D-aspartate (NMDA) receptors, voltage-gated Ca 2+ -channels (VGCC) (Bloodgood and Sabatini 2007; Simms and Zamponi 2014) and Ca
2+
-release from intracellular stores (Johenning et al. 2015) . Among high-voltage gated Ca 2+ -channels, L-type VGCCs (Cav1) are crucially involved in the regulation of STDP, by their involvement in backpropagating action potentials (Markram et al. 1995; Bloodgood and Sabatini 2007) . Conversely, activation of dendritic T-type VGCCs (Cav3) by small membrane depolarizations generates Ca 2+ spikes (Schiller et al. 1997 ) that may trigger local synaptic plasticity (Golding et al. 2002; Remy and Spruston 2007) . Although modeling work (Huang et al. 2011; Robinson 2013, 2014) has shown to successfully translate experimental results of cellular physiology to models of system-level plasticity by incorporating Ca 2+ dependent plasticity, how Ca 2+ channels influence different types of LTPand LTD-like plasticity in vivo in humans remains largely unknown.
Here, we addressed this issue. Based on the similarity of design of plasticity protocols with established protocols of LTP-induction in animal work and based on models of system level plasticity in humans (Huang et al. 2011; Robinson 2013, 2014) , we hypothesized that different Ca 2+ -channels would modulate plasticity of corticospinal excitability induced by TBS and PAS differently. We first examined the effect of pharmacological blockade of different Ca 2+ channels on PAS-induced plasticity. To enable comparison with TBS stimulation we, secondly, employed continuous TBS (cTBS; bursts repeated for a duration of 20 s totalling 300 pulses), a protocol variant of TBS which enhances corticospinal excitability in the human corticospinal system (Gentner et al. 2008; Wankerl et al. 2010 ). CTBS at 300 pulses was favored over intermittent TBS (Huang et al. 2005 ) to maintain comparability with previous work (Gentner et al. 2008; Wankerl et al. 2010) , and because its design principle has strong similarity to LTP-induction protocols established in vivo. The combined blockade of L-Type VGCC and NMDA receptors was investigated in order to maintain a parallel design to our previous work (Wankerl et al. 2010) and to enable comparison across plasticity protocols.
Materials and Methods

Subjects
The study was performed on 25 right-handed (handedness was assessed by self-report) healthy volunteers (14 females) aged 18-29 years (mean: 22.5 ± 2.8 years, Table 1 ). None of the subjects had contraindications to TMS (Rossi et al. 2009 ).
None of them had a history of neurological illness, or was under any medication acting on the central nervous system. A total of 5 out of the 25 participants (20%) were smokers. Smokers were allowed to follow their usual nicotine consumption habit, to avoid effects of nicotine withdrawal (Grundey et al. 2012 ). All participants gave their written informed consent. The study was approved by the Ethics committee of the University of Leipzig (No. 231-09-28092009) .
The study conformed to TMS study quality criteria (Chipchase et al. 2012) .
Stimulation
Focal TMS was performed using a figure-of-eight shaped magnetic coil (outer diameter of each wing 70 mm) that was held tangentially to the skull with the handle pointing backwards and laterally at an angle of 45°to the sagittal plane (direction of current induced in the brain: posterior to anterior, PA). Experiments were performed by connecting the coil to a Magstim 200 stimulator (Magstim, Whitland, Dyfed, UK) with monophasic pulse configuration. In the experiments employing continuous Theta Burst Stimulation (cTBS, Expt. 2) the coil was connected to a MagPro X100 magnetic stimulator (Medtronic, Minneapolis, USA). Here, the pulse shape was either monophasic (PA induced current in the brain) or biphasic (initially AP induced current in the brain), as detailed later. For electrical median nerve (MN) stimulation at the wrist, a standard stimulation block (cathode proximal) connected to a Digitimer DS7A stimulator (Digitimer Ltd., Welwyn Garden City, UK) was used. Stimulus intensity was set at 300% of the perceptual threshold and stimulus duration at 200 µs. 
Experimental Procedures and Measures of Corticospinal Excitability
Subjects were seated comfortably in a reclining chair. The optimal position of the magnetic coil for eliciting motor evoked potentials (MEPs) in the resting APB of the dominant hand ("hotspot"), was assessed over the contralateral primary motor cortex at a moderately suprathreshold stimulation intensity, using monophasic pulses. To ensure stability of the stimulation position over the course of an experiment, the hotspot was registered by a neuronavigation system (Brainsight, Rogue Research, Montreal, Canada) and also marked directly on the scalp with a soft-tip pen. Resting motor threshold at monophasic pulse configuration (RMT Mono ) was determined as the minimum stimulator intensity needed to produce a response of at least 50 µV in the relaxed APB in at least 5 of 10 consecutive trials (Rossini et al. 2015) . For the cTBS experiment (Expt. 2), the threshold was additionally assessed with biphasic pulse configuration in the same way (RMT Bi ). Input-output curves (IOCs). Eleven different stimulation intensities (SI, 90, 95, . .. , 140 % of RMT Mono ) were recorded in a pseudorandomized order. For each intensity 12 MEPs were collected at 0.2 ± 10% Hz. Mean amplitudes for each subject and each SI were calculated.
Assessment of induced changes of corticospinal excitability. For monitoring changes in corticospinal excitability, SI producing MEP amplitudes of~1 mV at rest (SI 1mV ) was assesed using monophasic single pulse TMS. The same SI was used before and after intervention with the target muscle at rest. Baseline corticospinal excitability (before intervention by PAS and cTBS, see later) was probed by collecting 30 MEPs at SI 1mV (0.2 ± 10% Hz). After the interventions, excitability changes were monitored by collecting 12 MEP responses (0.2 ± 10% Hz) every 2 minutes following the intervention for up to 33 min (16 blocks, starting with 2 min of rest, then 1 min measurement, 1 min rest, … , Figure 1A and 2A; [Wankerl et al. 2010] ). Our choice for the duration of monitoring of the after-effects was based on a number of previous pharmacological studies demonstrating that the pattern of plasticity effects using PAS and TBS protocols is expressed within some 10-15 min (Kuo et al. 2007 (Kuo et al. , 2008 Koch et al. 2009; Heidegger et al. 2010; Thirugnanasambandam et al. 2011) . Although monitoring corticospinal excitability for extended time periods might reveal delayed effects, late phenomena would most likely result from overlapping physiological mechanisms.
Subjects were instructed to pay attention to their hand during the whole intervention. In addition, subjects were admonished and provided with auditory feedback to maintain complete muscular relaxation throughout the experiment.
Interventions
Paired associative stimulation (PAS25 and PAS5000). PAS was performed by combining repetitively (90 pairs) electric stimulation of the MN of the dominant hand with subsequent TMS of the hotspot of the contralateral M1 with a SI of 1.3 × RMT Mono (Stefan et al. 2000) over a period of 15 min (0.1 Hz). The interstimulus interval (ISI) was 25 ms (PAS25) or 5000 ms (PAS5000, Expt. 1). Previous experiments (Stefan et al. 2000) have shown that PAS applied at an ISI of 5000 ms does not change corticospinal excitability. Hence, PAS5000 served as a control intervention without own excitability changing capacity, matching PAS25 in duration and the number of TMS pulses and peripheral nerve pulses.
Continuous theta-burst stimulation (cTBS; Gentner et al. 2008; Huang et al. 2005) . CTBS was perfomed by applying TMSbursts of 3 pulses (biphasic pulse configuration) at 50 Hz repeated at 200 ms intervals for a duration of 20 s (300 TMS pulses in total) over the hotspot of the contralateral motor cortex. SI was set at 0.7 × RMT Bi (Expt. 2). Excitability changes were monitored by TMS before and after PAS-intervention. Effects of PAS and/or cTBS on MEP amplitude were expressed as percent difference compared to baseline MEP amplitudes. All experimental sessions were separated by at least 48 h.
Pharmacological interventions
The following drugs or their combination were used: Nimodipine (NDP). NDP, a blocker of L-type voltage gated Ca 2+ -channels (Hess et al. 1984) , was administered orally to the subjects in a single dose of 30 mg (Nimodipin Hexal, Hexal, Holzkirchen, Germany). In humans, NDP at 30 mg results in cerebral concentrations (Allen et al. 1983 ) similar to those shown to block induction of LTP by high-frequency stimulation in rat hippocampus after intracerebroventricular injection of NDP (Lin et al. 2002) . Although single NDP doses in excess of 30 mg are justified for treatment of life-threatening vasospasms following subarachnoid hemorrhage, higher doses were not applied in the present experiments for safety concerns. Ethosuximide (ESM), a blocker of T-type voltage gated Ca 2+ -channels (Gören and Onat 2007) , was taken by subjects in a dose of 750 mg. A higher ESM dose of 1000 mg was found intolerable in pilot experiments conducted on some of the authors. ESM is not bound to plasma proteins and its level in cerebrospinal fluid is similar to those in plasma (15 μg/ml after a single 750 mg oral dose [Gören and Onat 2007] ). Dextromethorphan (DXM) is a NMDA-R antagonist (Wong et al. 1988; Stahl 2013) . Subjects received 120 mg of DXM (Hustenstiller-Ratiopharm, Ratiopharm, Ulm, Germany). At this dose, DXM leads to cerebral concentrations (Hollander et al. 1994; Steinberg et al. 1996) known to block NMDA-R in vitro (Wong et al. 1988; Apland and Braitman 1990) .
Study Design
Effect of NDP, DXM + NDP, and ESM on Corticospinal Excitability and PAS25-Induced Plasticity (Expt. 1a) Thirteen healthy volunteers (aged 18-29 years) participated in 4 different sessions each (Table 2 , sessions 1-4). In sessions 1 and 2 subjects received placebo (PBO) and NDP (30 mg), respectively. In session 3, DXM (120 mg) and NDP (30 mg) was adminstered, in session 4 ESM (750 mg) and PBO. Sessions 1 and 2 as well as sessions 3 and 4 were performed in a double-blind counterbalanced design. RMT Mono , IOCs and 30 TMS-pulses at SI 1mV were used as described above to determine native motor excitability (t0) and again, just before the PAS-intervention (tM), to assess pharmacological effects on static, untreated motor cortex excitability. PAS25 was timed to start 45 min after application of NDP (30 mg) (He et al. 2004 ) and PB0 and 150 min after application of DXM (120 mg) (Hollander et al. 1994; Steinberg et al. 1996) and ESM (750 mg) (Gören and Onat 2007) in order to synchronize the intervention with the near timing of peak drug concentration. A schematic overview of the experimental design is provided in Figure 1A . 
Experiment 1a (n = 13) PAS25 PBO 50 ± 2.5 -69 ± 3.9 0.9 ± 0.04 0.9 ± 0.05 PAS25 NDP 30 mg 50 ± 2.5 -69 ± 3.8 1.1 ± 0.05 1.1 ± 0.05 PAS25 DXM 120 mg + NDP 30 mg 50 ± 2.5 -70 ± 3.8 1.0 ± 0.07 1.4 ± 0.05 PAS25 ESM 750 mg + PBO 50 ± 2.5 -69 ± 3.8 1.0 ± 0.05 1.0 ± 0.05 Experiment 1b (n = 11) PAS25 DXM 120 mg + PBO 49 ± 2.3 -67 ± 2.7 1.1 ± 0.05 1.2 ± 0.05 PAS5000 DXM 120 mg + NDP 30 mg 50 ± 2.4 -70 ± 3.4 1.1 ± 0.05 1.6 ± 0.18 Experiment 2 (n = 16) cTBS PBO 48 ± 2.5 42 ± 2.1 69 ± 3.6 -0.9 ± 0.06 cTBS ESM 750 mg 48 ± 2.4 43 ± 2.2 70 ± 3.5 -0.9 ± 0.05 RMT Mono , resting motor threshold, established with a monophasic pulse configuration; RMT Bi , resting motor threshold, established with a biphasic pulse configuration; Motor thresholds are given in percentage of maximum stimulator output. SI1mV, stimulation intensity producing MEP amplitudes of~1 mV at rest; MEPt0 and MEPtM, MEP amplitude at t0 and tM, respectively. Data are mean ± SEM. No differences were found between conditions for a given measure and experiment.
Effect of the Combination of DXM and NDP on Static Corticospinal Excitability and PAS25-induced Plasticity (Expt. 1b) Eleven out of the 13 healthy subjects from Expt. 1a (aged 18-29 years) participated in Expt. 1b (Table 2 , sessions 5 and 6). They were tested in a further 2 pseudorandomized, singleblinded sessions each. In 1 session, DXM (120 mg) and PBO were administered before applying PAS25. In the second one, DXM (120 mg) was again combined with NDP (30 mg) (as in Expt. 1a), but PAS was performed using an ISI of 5000 ms (PAS5000). The experimental time-line was the same as in Expt. 1a (Fig. 1A) .
Effect of ESM on cTBS-Induced Plasticity (Expt. 2) Sixteen healthy volunteers (aged 19-28 years) were examined in 2 sessions in a double-blind, counterbalanced design (Table 2 ). In 5 subjects (out of 16, mean age: 22.7 ± 3.1 years, 3 females) also PAS25 was performed in a double-blind design. Subjects received either ESM (750 mg) or PBO. Experimental design was similar to Expt. 1b, but no IOCs were assessed ( Fig. 2A) . CTBS was again timed to be performed 150 min after application of DXM (120 mg) and PBO. For each subject, 30 MEP-amplitudes were averaged before (t0, Expt. 1) and after application of medication (tM, Expt. 1 and 2). For statistical analyses, post interventional values were binned at 2 time points (t1: 3, 5, 7, 9, 11, 13, 15, 17 min following PAS and TBS, respectively; t2: 19, 21, 23, 25, 27, 29, 31 , 33 min; 96 responses each) to reduce variability of results. Since Kolmogorov-Smirnov tests had indicated that MEP raw data were normally distributed, MEP baseline comparisons (Expt. 1 t0; Expt. 2 tM) were performed by ANOVA RM and two-tailed paired t-tests, respectively. All averaged MEP-amplitudes were normalized to tM assessed directly before PAS/cTBS-intervention in order to compare the effect of interventions on corticospinal excitability. The factors tested with ANOVA RM are explained in more detail in the Results section.
Mauchly's test was used to test for nonsphericity of the data. In case of non-sphericity, Huynh-Feldt correction for P values was applied. For post-hoc testing of significant F-test results, two-tailed Student t-tests were performed. The false discovery rate correction procedure was used for correction for multiple comparisons (Curran-Everett 2000) . Effects were considered significant, if P < 0.05. All data are presented as means ± SD if not stated otherwise.
Results
Blockade of L-Type VGCC Blocks, Blockade of T-type VGCC Reverses Direction of, PAS-Induced Plasticity (Expt. 1a)
We tested the effect of pharmacologic modulators of different Ca 2+ channels applied individually or in combination on IOC, a parameter of corticospinal excitability sensitive to glutamatergic synaptic transmission in elements presynaptic to the pyramidal output neuron (Table 3 and Fig. 1B) . IOC was neither altered by PBO nor by NDP (30 mg) nor by ESM (750 mg) (Table 3 ). This result is consistent with the finding that L-and T-type VGCCs are not substantially involved in the control of glutamate release from presynaptic nerve terminals (Catterall 2011) . However, application of DXM + NDP increased the steepness of IOCs (Table 3 and Fig. 1B ). This unexpected finding was investigated further in experiment 1b (see later). Excitability following PAS25 changed as a function of the medication (Table 3 and Fig. 1C ). After intake of PBO, PAS25 resulted in an increase of corticospinal excitability in agreement with previous observations (Stefan et al. 2000) . However, NDP (30 mg) blocked the PAS25-induced facilitation while the direction of PAS25-induced excitability changes switched from facilitation to depression under the influence of ESM (750 mg). In contrast, under the influence of DXM + NDP corticospinal excitability increased following PAS25 (Table 3 and Fig. 1C and D) .
Combined Blockade of NMDA-R and L-Type VGCC Blocks PAS-Induced Plasticity, but Enhances Corticospinal Excitability (Expt. 1b)
As noted earlier, the prevailing assumption is that synaptic potentiation underlies the excitability enhancing effect of PAS25 in the naïve cortex (Cooke and Bliss 2006; Müller-Dahlhaus et al. 2010 ). The increase of corticospinal excitability following PAS under the influence of the combination of DXM and NDP appears to be inconsistent with this hypothesis, as synaptic potentiation would seem unlikely to occur in the presence of the combined blockade of NMDA-receptors by DXM (Wong et al. 1988; Stahl 2013 ) and blockade of L-type voltagegated Ca 2+ -channels by NDP (Hess et al. 1984) . To examine this unexpected finding further, we first re-examined the effect of DXM alone on PAS25. DXM was previously shown to block the facilitating effects of PAS25 (Stefan et al. 2002) and the depressant effects of PAS10 (Wolters et al. 2003) . We secondly considered the possibility that, since DXM + NDP enhanced excitability at baseline, the increase after PAS25 may have resulted from a prolonged increase in static excitability as a consequence of the medication alone. These issues were investigated by applying PAS25 under the influence of DXM (120 mg) + PBO, and, in a different experimental session, by applying PAS5000 (a PAS protocol unable to induce corticospinal excitability changes [Stefan et al. 2000] ) under the influence of DXM (120 mg) and NDP (30 mg) (Fig. 1A) . With PAS5000, physiological events evoked by either stimulus modality (afferent nerve stimulation and TMS) occur asynchronously and, hence, cannot interact.
Baseline mean MEP values (t0) did not differ between conditions (two-tailed Student t-test, P = 0.321). In agreement with previous studies (Ziemann et al. 1998; Wankerl et al. 2010 ) DXM (120 mg) + PB0 had no effect on IOC (Table 3 and Fig. 1B) suggesting that DXM at a dose of 120 mg did not alter presynaptic glutamatergic transmission. DXM blocked PAS-induced facilitation (Table 3 and Fig. 1C ) corroborating earlier findings (Stefan et al. 2002) . Results were compared with those obtained in the same subjects tested in Expt. 1a under the influence of PBO (Fig. 1D ). This comparison revealed significantly smaller MEP amplitudes with PAS25 under the influence of DXM compared with PBO (Table 3 ). The combination of DXM (120 mg) and NDP (30 mg) resulted in an increase of static excitability as indicated by a steeper IOC, confirming results obtained in experiment 1a (Table 3 and Fig. 1B) . PAS5000 under the influence of DXM + NDP led to enhancement of excitability (Table 3 and Fig. 1B) . Importantly, the excitability enhancement under DXM + NDP following PAS5000 did not exceed that observed after PAS25 under the influence of DXM + NDP (comparison using combined results from Expt. 1a and Expt.1 b, Table 3 and Fig. 1D ). Hence, this observation suggests that the increase following PAS under the influence of DXM + NDP was entirely explained by the effects of DXM (120 mg) + NDP (30 mg) on excitability alone. Importantly, since PAS25 did not enhance excitability over and above that observed following PAS5000, when both interventions were performed under DXM + NDP, this result suggested that the combination had blocked the excitability enhancing effect of PAS25.
Thus, the results of experiment 1 revealed that the facilitatory PAS-effect was blocked by NDP or DXM alone as well as by the combination of both. In contrast, ESM led to a switch from a facilitatory to a depressant effect of PAS25. 
Blockade of T-Type VGCC Blocks cTBS-Induced Plasticity (Expt. 2)
In previous work (Wankerl et al. 2010) we studied the effect of L-type Ca 2+ -channel blocker NDP or NMDA-R blocker DXM on cTBS-induced plasticity. We found that NDP resulted in a switch from an excitability enhancing, LTP-like effect to an excitability depressant, LTD-like effect of cTBS whereas the combination of NDP (30 mg) + DXM (120 mg) led to a complete blockade of any cTBS-effect (Wankerl et al. 2010) . To study Ca 2 + -entry in cTBS-induced plasticity more comprehensively and enable comparison of the pattern of Ca 2+ -dependent modulation of PAS-induced plasticity with that of cTBS, we examined the effect of blocking T-type Ca 2+ -channels by ESM. Baseline mean MEP values (tM) did not differ between conditions (twotailed Student t-test, P = 0.428). CTBS resulted in an increase of MEP amplitudes under PBO, whereas cTBS-induced facilitation was abolished under the influence of ESM (750 mg) (Table 4 and Fig. 2B,C) .
To compare ESM-modulation of plasticity between PAS and cTBS directly, we compared responses in a group of 12 participants subjected to both protocols (Fig. 3A) . Baseline mean MEP values (tM) did not differ between conditions (ANOVA RM F(3.33) = 0.532, P = 0.663). Results from all subjects taking part in both protocols were analysed by ANOVA RM . This revealed a significant INTERVENTION × DRUG × TIME interaction indicating that the effect of ESM on plasticity differed between interventions (PAS and cTBS, respectively, Table 4 ). Subsequent ANOVA RM (TIME [tM, t1, t2]) was performed for each intervention (PAS, cTBS). ESM (750 mg) reversed the effect of PAS25 from facilitation to depression whereas the effect of cTBS was attenuated (Table 4) .
Discussion
The present study showed that PAS-induced enhancement of corticospinal excitability was differentially modulated by drugs interacting with sources of Ca 2+ entry. Furthermore, the pattern of modulation differed from that established for a facilitatory cTBS variant in this and previous work.
Multiple Ca 2+ Channels Influence PAS-Induced Plasticity PAS applied at an interstimulus interval of 25 ms enhanced corticospinal excitability, in line with previous observations (Stefan et al. 2000) . The present study also confirmed previous results that NMDA-R blockade by DXM prevented PAS-induced facilitatory effects on corticospinal excitability (Stefan et al. 2002) . The new findings were that (i) blockade of L-type VGCC by NDP (30 mg) was sufficient to block excitability enhancement, whereas (ii) blockade of T-type VGCC by ESM (750 mg) reversed the direction of changes from facilitation to depression. Physiological characteristics of PAS-induced enhancement of corticospinal excitability resemble associative LTP of excitatory synapses (Müller-Dahlhaus et al. 2010 ) although the contribution of neuronal excitability changes cannot be excluded (Carson and Kennedy 2013) . Since NDP, ESM, and DXM all influence Ca 2+ entry into the postsynaptic neuron, the present findings underline the importance of Ca 2+ -influx as a major determinant for the plasticity-inducing effects of PAS. Lamotrigine, which, in addition to Na + -channels, also blocks Nand P/Q-type VGCCs, but not L-type VGCCs (Stefani et al. 1996) , did not significantly affect PAS-induced enhancement of corticospinal excitability in a study by Heidegger and co-workers (2010) . Therefore, postsynaptic L-and T-type Ca 2+ channels may have a more prominent role for PAS-induced plasticity compared to other VGCC species. Given the central role of postsynaptic Ca 2+ -dynamics in synaptic plasticity (Bloodgood and Sabatini 2007) , strong modulation of PAS-induced plasticity by NDP, ESM, and DXM is consistent with the synaptic hypothesis.
According to an influential theory (Lisman 1989; Artola and Singer 1993) , whether LTP or LTD is induced, depends on the magnitude and dynamics of the different postsynaptic levels of Ca 2+ induced by the stimulation (Graupner and Brunel 2012) .
Under the influence of ESM (750 mg ] was insufficient to induce any synaptic change (Sjöström and Häusser 2006) . The combination of DXM and NDP led to an enhancement of static excitability which is likely associated with enhanced spontaneous neuronal firing (as discussed later).
Differential Physiology of PAS-and cTBS-Induced Plasticity
Each of the above findings alone does not allow us to determine the relative importance of the different postsynaptic Ca 2+ -sources for PAS-induced plasticity, because we have studied each Ca 2+ -entry blocker only at a single dose, and because we do not know to which degree a specific Ca 2+ -channel type was affected. However, comparison with the effect of Ca 2+ -channel blockers on cTBS-induced plasticity may provide a clue on physiological mechanisms of both plasticity induction protocols.
In previous work, we found that the excitability enhancing effect of cTBS was blocked by application of DXM and DXM + NDP (Wankerl et al. 2010) . NDP (30 mg) alone, however, reversed the enhancing effect of cTBS to a depressant one (Wankerl et al. 2010) . In the present study we showed that blockade of T-type VGCC by ESM substantially weakened the efficacy of cTBS. Combined, these findings demonstrate that cTBS-induced facilitatory plasticity is influenced by NMDA-R, and L-type VGCC, but also by T-type VGCC. Additionally, it shows that, while both PAS and TBS appear to share NMDA-R dependency, they are influenced differently by L-type and T-type VGCCs. The different sensitivity may point to different relative weights and potentially different roles of these channels in generating synaptic changes. Complete blockade of excitability changes by a particular Ca 2+ -channel species may indicate a gating or permissive role of that species. This Ca 2+ -channel may not necessarily be located at the synapse, which is being modulated. Conversely, because only local [Ca 2+ ]-changes determine whether LTP or LTD is generated, only a location very close to the altered synapse, probably at the synaptic spine, would endow a Ca 2+ -channel with the property of a mechanism regulating polarity as implicated by bidirectional modulation of excitability changes.
L-type and T-type VGCCs are both located postsynaptically and are differentially distributed on the neuron's dendritic tree (Johnston et al. 1996; Bloodgood and Sabatini 2008) . T-type VGCCs are known to be located in apical dendrites and spines, but appear to be less prevalent in basal dendrites or soma (Johnston et al. 1996; Almog and Korngreen 2009) . Therefore, the fact that PAS-induced facilitation is switched to depression by blockade of T-type VGCC is consistent with the hypothesis that PAS-induced synaptic changes are located in superficial cortical layers (Wolters et al. 2005; Weise et al. 2013; Di Lazzaro and Rothwell 2014) . Conversely, L-type VGCC are predominantly located near the soma of pyramidal neurons (Westenbroek et al. 1990; Hell et al. 1993) , where they contribute Ca 2+ -transients to enable backpropagating action potentials (b-APs) (Williams and Stuart 2000) . As b-APs provide the postsynaptic signal required for STDP (Magee and Johnston 1997) , blockade of L-type VGCCs may result in blocking PAS-induced plasticity. Similarly, blockade of cTBS-induced facilitation by T-type VGCCs may suggest that EPSPs summating during TBS produce cooperative LTP owing to the occurrence of Ca 2+ -dependent regenerative spikes initiated in the dendrites (Schiller et al. 1997) . However, we cannot rule out the possibility that in one or both protocols Ca 2+ -influx was blocked to an intermediate level where no net change of synaptic plasticity would be expressed (so called "no man's land" [Lisman 2001] ).This issue could be addressed by testing higher doses by which Ca 2+ -influx could be further reduced, which then would induce a net depressant effect on corticospinal excitability at moderately higher concentrations, before at still higher concentrations modulation of corticospinal excitability would be blocked altogether. The inability to employ higher doses in the current experiments precluded us from addressing this issue directly.
Although conclusions on mechanisms at the macroscopic level are by necessity indirect and speculative, we have attempted to illustrate the hypothesis about different physiological concepts underlying PAS-and cTBS-induced plasticity in Figure 3B . As noted above, this hypothesis is solely based on documented mechanisms at the level of single glutamatergic neurons and inevitably simplistic. Alternative, more complex, or multiple mechanisms might have been operative. For example, the influence of different VGCC on afferent sensory processing (Jevtovic-Todorovic and Todorovic 2006; MartinezGomez and Lopez-Garcia 2007; Deleuze et al. 2012) , which is prominent in PAS, but probably absent in cTBS might have contributed to the different effects. Blockade of VGCC on cortical, mainly GABAergic interneurons could also play a role, as these interneurons likely modulate PAS- (Elahi et al. 2012; Weise et al. 2013 ) and TBS-induced plasticity (Benali et al. 2011; Hamada et al. 2013 ).
Increase of Static Corticospinal Excitability by Blockade of L-Type Ca
2+ Channels and NMDA-Rs
We observed that the combination of DXM and NDP enhanced the steepness of IOCs, a finding that was replicated in a second independent experiment (Expt. 1b). This observation is surprising because, if anything, blockade of a major excitatory neurotransmitter receptor by DXM (Wong et al. 1988; Stahl 2013) , along with blockade of L-type VGCCs, would have appeared to more likely reduce, instead of enhance, excitability. Enhancement of corticospinal excitability by DXM + NDP is reminiscent of the effect of ketamine, a blocker of NMDA-R in subanaesthetic dosages (Stahl 2013) . Ketamine increased MEP amplitudes at rest (Di Lazzaro et al. 2003) , and enhanced intracortical facilitation, while reducing intracortical inhibition (Höffken et al. 2013 ). The authors suggested that ketamine, by virtue of blocking NMDA-Rs, may have increased the release of the endogenous excitatory amino acids glutamate and aspartate (Moghaddam et al. 1997 ) resulting in paradoxical enhancement of neuronal excitability, likely through indirect AMPA receptor activation. This effect is thought to arise from blockade of tonic GABAergic input to cortical glutamatergic afferents (Moghaddam et al. 1997) . Indeed, NMDA antagonist treatment with MK801 potentiated the neuronal firing rate in prefrontal cortex in freely moving rats (Jackson et al. 2004 ). However, DXM (120 mg) alone did not enhance excitability, but required the presence of NDP (30 mg). Thus, NDP synergistically increased the effect of NMDA-R blockade, which might provide insights into the mechanisms how NMDA-R blockade increases excitability (Kavalali and Monteggia 2012) . We are aware of some limitations of the study. First, we used only single dosages and did not generate dose response curves. Furthermore, for practical reasons, we decided against employing a fully double-blinded, cross-over design as it was difficult to recruit subjects for a large number of consecutive pharmacological experiments. Although the drugs used have high affinity for certain Ca 2+ -channels, affinity may not be selective and interaction with other receptors or channels cannot be ruled out. Finally, while the present results are in line with the synaptic nature of plastic changes following PAS and cTBS, whether and to which degree other plasticity mechanisms (Carson and Kennedy 2013) contribute to the observed effects remains unknown.
Conclusions
We have demonstrated that PAS-induced facilitation of corticospinal excitability is modulated by different types of Ca 2+ channels. Whereas PAS and cTBS share NMDA-R dependency, L-and T-type VGCCs appear to be differentially involved. We hypothesize that L-type VGCCs may gate PAS-induced plasticity, possibly by their involvement in b-APs, supporting similarity of PAS-induced plasticity with STDP. In contrast, the effect of blocking T-type VGCCs on cTBS-induced plasticity could be explained by blockade of dendritic spike generation. Although this simplified model accounts for known physiological facts about cellular Ca 2+ physiology, alternative or more complex models cannot be excluded.
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